TransEnterix Submits 510(k) Application to FDA for SurgiBot System

First Patient-Side Robotically Enhanced Laparoscopic Surgery Platform

RESEARCH TRIANGLE PARK, N.C.--(Healthcare Sales & Marketing Network)--TransEnterix, Inc. (NYSE MKT:TRXC), a medical device company that is pioneering the use of robotics and flexible ... Devices, Surgery, FDATransEnterix, SurgiBot, laparoscopy

Source: HSMN NewsFeed - June 1, 2015 Category: Pharmaceuticals Source Type: news